Image

Asia-Pacific Medical Foods for Inborn Errors of Metabolism Market – Industry Trends and Forecast to 2027

  • Medical Devices
  • Published Report
  • May 2020
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 207
  • No of Figures: 25
  • Medical Devices
  • Published Report
  • May 2020
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 207
  • No of Figures: 25

Asia-Pacific Medical Foods for Inborn Errors of Metabolism Market By Products (Amino Acid, Low Protein Food, Glytactin with GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, Others), Age Group (Infants, Weaning, Adolescent, Adults), Diseases (Phenylketonuria (PKU), Tyrosinemia Types I and II, Maple Syrup Urine Disease (MSUD), Homocystinuria, Glutaric Acidemia Type I, Urea Cycle Disorders, Methylmalonic Acidemia, Isovaleric Acidemia, Organic Acidurias, Renal Disease, Propionic Acidemia, Disorders of Leucine Metabolism, Others), Form (Powder, Liquids, Others), Packaging (Can, Packets, Bottle, Jar, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Drugs Stores, Online Pharmacies, Others), Country (China, Japan, India, Australia, South Korea, Thailand, Singapore, Indonesia, Malaysia, New Zealand, Vietnam, Philippines, Rest of Asia-Pacific)  Industry Trends and Forecast to 2027

Asia-Pacific Medical Foods for Inborn Errors of Metabolism Market Market Analysis and Insights: Asia-Pacific Medical Foods for Inborn Errors of Metabolism Market

Asia-Pacific medical foods for inborn errors of metabolism market are expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with the CAGR of 15.3% in the forecast period of 2020 to 2027 and expected to reach USD 882.67 million by 2027. Increasing birth rate with incidence of IEM disease each year in Asia-Pacific is helping the market to grow in the region.

Medical food is the specialized food which is manufactured under certain guidelines. These products are highly nutritive and are useful for the treatment of metabolic related disease. Increasing cases of diseases of IEM has leaded the manufacturer to develop these products which can help patient to overcome their health issues.

This Medical Foods For Inborn Errors of Metabolism Market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographical expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Medical Foods for Inborn Errors of Metabolism Market Asia-Pacific Medical Foods for Inborn Errors of Metabolism Market Scope and Market Size

Medical foods for inborn errors of metabolism market is segmented into six notable segments which are bifurcated on the basis of products, age group, diseases, form, packaging and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of products, the market is segmented into amino acid, low protein food, glytactin with GMP amino acid-modified infant formula with iron, low-calcium/vitamin D-free infant formula with iron and others. In 2020, amino acid segment is dominating the market as it has ability to improve the metabolic activity of patient suffering from inborn errors of metabolism. Major companies are also generating their revenue by providing products including amino acid based products as medical food.
  • On the basis of age group, the market is segmented into infants, weaning, adolescent and adults. In 2020, infants segment is dominating the market due to the incidence of diseases related to IEM is accounted high in infants or the babies they are just born. A medical food in powder or liquid from helps these babies to improve their metabolic activities and it ultimately helps the body growth of the infant.
  • On the basis of diseases, the market is segmented into phenylketonuria (PKU), maple syrup urine disease (MSUD), homocystinuria, methylmalonic acidemia, organic acidurias, propionic acidemia, isovaleric acidemia, disorders of leucine metabolism, glutaric acidemia type I, renal disease, tyrosinemia types I and II, urea cycle disorders and others. In 2020 phenylketonuria (PKU) segment is dominating the market as the prevalence of phenylketonuria is high in inborn error of metabolism. Also it has been observed that companies are more inclined in manufacturing medical foods for the PKU disease. For instance, Abbott, Nutricia and Biomerine are the major companies involved in providing medical food for PKU disease.
  • On the basis of form, the market is segmented into powder, liquids and others. In 2020, powder form is dominating the market as it is convenient for consumer and its shelf life is also long.
  • On the basis of packaging, the market is segmented into can, jar, packets, bottle and others. In 2020, can segment is dominating the market as it provide proper safety of product packed into it and it is also easy to maintain along with long shelf life.
  • On the basis of distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, drugs stores, online pharmacies and others. In 2020, retail pharmacy segment as the medical foods only taken under prescription by doctors or healthcare professionals.

Medical Foods for Inborn Errors of Metabolism Market Country Level Analysis

Medical foods for inborn errors of metabolism market is analysed and market size information is provided by products, age group, diseases, form, packaging and distribution channel.

The countries covered in the medical foods for inborn errors of metabolism market report are China, Australia, Japan, South Korea, New Zealand, India, Indonesia, Singapore, Thailand, Malaysia, Philippines, Vietnam and Rest of Asia-Pacific.

China is dominating the market as the birth rate is high and hence the incidence of IEM is also high among all countries which lead to high demand for the medical food. Hence the revenue generation from this country is high for the medical food for inborn errors of metabolism. Governments are taking initiatives for increasing awareness which ultimately will help to increase the demand in market.

The country section of the meat extract market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

The major players covered in the report are BioMarin, Mead Johnson & Company, LLC. (A Subsidiary of Reckitt Benckiser Group plc.), Nestlé Health Science (A Subsidiary of Nestlé), Ajinomoto Cambrooke, Inc. (A Subsidiary of Ajinomoto Co., Inc.), Dr. Schär AG / SPA, and Nutricia (A Subsidiary of Danone) among others domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

  • In November 2018, Cambrooke Therapeutics Inc.(Ajinomoto Cambrooke, Inc.) got the OU-D certification for its glytactin GMP metabolic formulas and ketogenic liquid formulas. This has helped in the treatment of people suffering from epilepsy. The certification was ensured of the product quality and safety. This has helped in gaining trust and also increased the revenue generation of the company in the market.               


SKU-
Why Choose Us


Frequently Asked Questions